Patent dispute over EPO is still underway

Published: 2002-10-10 06:59:00

Updated: 2002-10-10 06:59:00

In the recent patent dispute filed by Genetics Institute (GI) that Cheil Jedang's Epokine (erithropoietin), which was developed by the latter's own technology for the third time in the world, had infringed the former's patent on EPO, the Supreme Court reversed a patent court's ruling (No. 98-8243...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK